<?xml version="1.0"?>
<feed xmlns="http://www.w3.org/2005/Atom" xml:lang="en">
	<id>https://www.crsguidelines.org/index.php?action=history&amp;feed=atom&amp;title=SUCCINYLCHOLINE_%28ANECTINE%29</id>
	<title>SUCCINYLCHOLINE (ANECTINE) - Revision history</title>
	<link rel="self" type="application/atom+xml" href="https://www.crsguidelines.org/index.php?action=history&amp;feed=atom&amp;title=SUCCINYLCHOLINE_%28ANECTINE%29"/>
	<link rel="alternate" type="text/html" href="https://www.crsguidelines.org/index.php?title=SUCCINYLCHOLINE_(ANECTINE)&amp;action=history"/>
	<updated>2026-04-20T15:32:29Z</updated>
	<subtitle>Revision history for this page on the wiki</subtitle>
	<generator>MediaWiki 1.37.2</generator>
	<entry>
		<id>https://www.crsguidelines.org/index.php?title=SUCCINYLCHOLINE_(ANECTINE)&amp;diff=124&amp;oldid=prev</id>
		<title>Cgabryszek: Created page with &quot;&#039;&#039;&#039;Class&#039;&#039;&#039;  Short duration, depolarizing neuromuscular blocker  &#039;&#039;&#039;Pharmacology and Actions&#039;&#039;&#039;  # Succinylcholine is a short-acting, depolarizing skeletal muscle relaxant. ## Like acetylcholine, it combines with cholinergic receptors in the motor nerves to cause depolarization. ## Neuromuscular transmission is thus inhibited, which renders the muscles unable to be stimulated by acetylcholine. # Following IV/IO injection, complete paralysis is obtained within 60-90 secon...&quot;</title>
		<link rel="alternate" type="text/html" href="https://www.crsguidelines.org/index.php?title=SUCCINYLCHOLINE_(ANECTINE)&amp;diff=124&amp;oldid=prev"/>
		<updated>2022-04-04T03:59:30Z</updated>

		<summary type="html">&lt;p&gt;Created page with &amp;quot;&amp;#039;&amp;#039;&amp;#039;Class&amp;#039;&amp;#039;&amp;#039;  Short duration, depolarizing neuromuscular blocker  &amp;#039;&amp;#039;&amp;#039;Pharmacology and Actions&amp;#039;&amp;#039;&amp;#039;  # Succinylcholine is a short-acting, depolarizing skeletal muscle relaxant. ## Like acetylcholine, it combines with cholinergic receptors in the motor nerves to cause depolarization. ## Neuromuscular transmission is thus inhibited, which renders the muscles unable to be stimulated by acetylcholine. # Following IV/IO injection, complete paralysis is obtained within 60-90 secon...&amp;quot;&lt;/p&gt;
&lt;p&gt;&lt;b&gt;New page&lt;/b&gt;&lt;/p&gt;&lt;div&gt;&amp;#039;&amp;#039;&amp;#039;Class&amp;#039;&amp;#039;&amp;#039;&lt;br /&gt;
&lt;br /&gt;
Short duration, depolarizing neuromuscular blocker&lt;br /&gt;
&lt;br /&gt;
&amp;#039;&amp;#039;&amp;#039;Pharmacology and Actions&amp;#039;&amp;#039;&amp;#039;&lt;br /&gt;
&lt;br /&gt;
# Succinylcholine is a short-acting, depolarizing skeletal muscle relaxant.&lt;br /&gt;
## Like acetylcholine, it combines with cholinergic receptors in the motor nerves to cause depolarization.&lt;br /&gt;
## Neuromuscular transmission is thus inhibited, which renders the muscles unable to be stimulated by acetylcholine.&lt;br /&gt;
# Following IV/IO injection, complete paralysis is obtained within 60-90 seconds and persists for approximately 4 to 5 minutes.&lt;br /&gt;
## Effects then start to fade, and a return to normal is usually seen within 6 minutes.&lt;br /&gt;
## Muscle relaxation begins in the eyelids and jaw.&lt;br /&gt;
## It then progresses to the limbs, the abdomen, and finally the diaphragm and intercostals.&lt;br /&gt;
# It has no effect on consciousness.&lt;br /&gt;
&lt;br /&gt;
&amp;#039;&amp;#039;&amp;#039;Indications&amp;#039;&amp;#039;&amp;#039;&lt;br /&gt;
&lt;br /&gt;
# Succinylcholine is indicated to achieve temporary paralysis when endotracheal intubation is indicated and muscle tone or seizure activity prevents it.&lt;br /&gt;
&lt;br /&gt;
&amp;#039;&amp;#039;&amp;#039;Contraindications&amp;#039;&amp;#039;&amp;#039;&lt;br /&gt;
&lt;br /&gt;
# Penetrating eye injury&lt;br /&gt;
# Patients at risk for hyperkalemia (e.g., patients with crush or bum injuries greater than 24 hours old, severe renal failure or known dialysis patient.)&lt;br /&gt;
# Known hypersensitivity to the drug.&lt;br /&gt;
&lt;br /&gt;
&amp;#039;&amp;#039;&amp;#039;Precautions&amp;#039;&amp;#039;&amp;#039;&lt;br /&gt;
&lt;br /&gt;
# Succinylcholine should not be administered unless personnel skilled in endotracheal intubation are present and ready to perform the procedure.&lt;br /&gt;
# Cardiac arrest and ventricular arrhythmias can occur when Succinylcholine is administered to patients with severe bums and severe crush injuries.&lt;br /&gt;
&lt;br /&gt;
&amp;#039;&amp;#039;&amp;#039;Administration&amp;#039;&amp;#039;&amp;#039;&lt;br /&gt;
&lt;br /&gt;
# Adult:  100 mg IV/IO push&lt;br /&gt;
&lt;br /&gt;
&amp;#039;&amp;#039;&amp;#039;Side Effects and Special Notes&amp;#039;&amp;#039;&amp;#039;&lt;br /&gt;
&lt;br /&gt;
# Oxygen therapies and suction should be readily available, as should all emergency resuscitative drugs and equipment.&lt;br /&gt;
# This agent has no effect on consciousness, cerebration or pain threshold. Thus, it is crucial that an analgesic or sedative is administered prior to Succinylcholine.&lt;br /&gt;
# When the airway is secured after Succinylcholine administration and intubation, and further need for neuromuscular blockade is indicated, consider the administration of rocuronium (Zemeron).&lt;br /&gt;
# This agent may increase intragastric pressure, which could result in vomiting and possible aspiration of stomach contents.&lt;br /&gt;
# Lidocaine administration, prior to paralytic administration, reduces the rise in ICP associated with paralytic endotracheal intubation. This is especially important if there is already the possibility of ICP secondary to a head injury.&lt;/div&gt;</summary>
		<author><name>Cgabryszek</name></author>
	</entry>
</feed>